NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/03/2026
Voltar para busca
Dado oficial do USPTO
CARNA BIOSCIENCES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CARNA BIOSCIENCES
ST13
US500000079008908Classe
1, 5, 42
Pedido
79008908
Registro
3071237
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
11/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
04/01/2005
Data de registro
21/03/2006
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2026
Última transação
11/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
JP
Examinador
KHOURI, SANI PHILIPPE
Localização atual
Historical data usage
Titulares e representantes
Titulares
CARNA BIOSCIENCES, INC.
Representantes
Michael S. Hargis Stites & Harbison, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Peptide for in vitro research use and for scientific and medical research; polypeptide for in vitro research use and for scientific and medical research; protein for in vitro research use and for scientific and medical research; chemical reagents for non-medical purposes and non-veterinary purposes; and ferments for in vitro research use and for scientific and medical research
Classe 5
Chemical reagents for medical or veterinary purposes [; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; diagnostic preparations for medical purposes; drugs for medical purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; medicines for human purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; organotherapy preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; serotherapeutic medicines for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for skin care; biological preparations for medical purposes; and ferments for medical or veterinary use ]
Classe 42
[ Bacteriological research; ] biological research; [ chemical analysis; chemical research; chemistry services; cosmetic research; mechanical research; calibration measuring; and ] biological or chemical research consultancy
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
10/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2026
ES71
TEAS SECTION 71 RECEIVED
10/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/10/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/10/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
27/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/10/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/10/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/10/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
21/03/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/10/2024
RINX
USPTO CORRECTION PROCESSED BY IB
17/01/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
13/09/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
13/09/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/05/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
18/01/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
18/01/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/12/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/04/2016
71AG
REGISTERED-SEC.71 ACCEPTED
04/04/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/02/2016
ES71
TEAS SECTION 71 RECEIVED
13/01/2016
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
21/03/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
19/03/2015
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/03/2015
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
28/03/2014
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
13/02/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/11/2013
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/03/2013
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/06/2012
71AG
REGISTERED-SEC.71 ACCEPTED
12/06/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2012
ES71
TEAS SECTION 71 RECEIVED
16/03/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/11/2007
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
14/12/2006
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/10/2006
FIMP
FINAL DISPOSITION PROCESSED
24/10/2006
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/10/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
21/03/2006
PUBO
PUBLISHED FOR OPPOSITION
27/12/2005
NPUB
NOTICE OF PUBLICATION
07/12/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/11/2005
ALIE
ASSIGNED TO LIE
04/11/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
19/10/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2005
PAPER RECEIVED
05/10/2005
RFNT
REFUSAL PROCESSED BY IB
25/08/2005
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/08/2005
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/08/2005
CNRT
NON-FINAL ACTION WRITTEN
08/08/2005
DOCK
ASSIGNED TO EXAMINER
04/08/2005
NWAP
NEW APPLICATION ENTERED
25/03/2005
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/03/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CARNA BIOSCIENCES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.